Welcome Guest
Sign In
Register
Products
Popular Categories
Antibody Search
ELISA Kit Search
Biomolecules
Flow Cytometers
Thermal Cyclers
Microscopes
Transfection Reagents
Featured Products
New Products
Applications
ELISA
Western Blot
3D Cell Culture
PCR
Quantitative PCR
Digital PCR
Cell and Gene Therapy
In Vivo Models
Resources
eBooks
Bench Tips
Tech Insights
Editorial Articles
News
Product Reviews
Future Lab
Application Notes
Infographics
Events
Promotions
Multimedia
Biocompare Webinars
Technologies Transforming Precision Medicine
Immunotherapy
Reproducibility
Transformative Technologies
Podcasts
Bench Tip Videos
All Videos and Webinars
Life Science Webinars
Write a Review
Antibodies
Kits/Reagents
Equipment
Services
Register
Sign In
Biocompare
Products
Protein Biochemistry
Chemicals and Reagents
Zoledronic Acid
Zoledronic Acid from MedChemExpress
Be the first to write a review!
Citations:
(11)
Supplier Page
Supplier Page from
MedChemExpress for
Zoledronic Acid
Get Pricing
Description
Zoledronic Acid (Zoledronate) is a third-generation bisphosphonate (BP), with potent anti-resorptive activity. Zoledronic Acid inhibits the differentiation and apoptosis of osteoclasts. Zoledronic Acid also has anti-cancer effects
Product Specs
Company Info
Citations
Reviews
Product Specs
Item
Zoledronic Acid
Company
MedChemExpress
Price
$96.00
Supplier Page
View Company Product Page
Catalog Number
HY-13777
Quantity
50 mg
Applications
Bioactivity, Structure and function analysis, ELISA, SDS-PAGE, Western blotting
Purity
99.91%
Type
Chemical
Molecular Weight
272.09
Molecule Name
Zoledronic Acid
Formula
C5H10N2O7P2
Research Area
Metabolic Disease; Cancer
Add to Compare List
MedChemExpress
1 Deer Park Drive, Suite F
MONMOUTH JUNCTION
,
NJ
08852
United States
Phone
: US Tel: 609-228-6898
US Fax: 609-228-5909
EU Tel: +4686500910
Email: sales@medchemexpress.com
eu.sales@MedChemExpress.com
Company Profile
Website:
medchemexpress.com
Citations (11)
(1)
Impaired function of Vγ9Vδ2 T cells in frail elderly
Immunity & Ageing
January 16, 2026
Hui Li, Xiaxuan Li, Hangyu Chen, Zhanqun Yang, Mengzhu Zheng, Yuan Xue, Yingying Yan, Jian Lin, Xuan Lai, Long Chen
fetal bovine serum (
Gibco
,
26010074
). The PBMCs were then stimulated with 5 µM of
Zoledronic acid
(
MCE
,
HY-13777
) for the first three days and recombinant human interleukin-2 (Tonglihaiyuan, GMP-TL906-0050) at a concentration
(2)
Chemical engineering of γδ T cells with cancer cell-targeting antibodies for enhanced tumor immunotherapy
National Science Review
June 27, 2025
Long Chen, Bo Cheng, Zhanqun Yang, Mengzhu Zheng, Tianyu Chu, Pan Wang, Tianhui He, Yuan Xue, Houyi Ren, Liting Zheng,
et al.
26010074
) at a density
of (1
–3) × 106 cells/mL. PBMCs were stimulated with 5 μM zoledronic acid (
MCE
,
HY-13777
) for the first 3 days and stimulated for 14 days with recombinant human interleukin-2 (T&L Biotechnology
(3)
Aerobic exercise prevents renal osteodystrophy via irisin-activated osteoblasts
JCI Insight
January 30, 2025
Meng Wu, Huilan Li, Xiaoting Sun, Rongrong Zhong, Linli Cai, Ruibo Chen, Madiya Madeniyet, Kana Ren, Zhen Peng, Yujie Yang,
et al.
for 4 weeks. For in vivo drug treatment,
mice
were i.p. treated with 100 μg/kg of zoledronic acid (
HY-13777
,
MedChemExpress
) once per week and with 150 IU/kg per of calcitriol (17938, Sigma-Aldrich) once per
(4)
Mevalonate pathway inhibition reduces bladder cancer metastasis by modulating RhoB protein stability and integrin β1 localization
Communications Biology
November 9, 2024
Gang Wang, Tianchen Peng, Liang Chen, Kangping Xiong, Lingao Ju, Kaiyu Qian, Yi Zhang, Yu Xiao, Xinghuan Wang
serum (FBS). The UM-UC-3 and HEK
293T cell
lines were cultured in DMEM (containing 10% FBS). ZOL (Cat. #
HY-13777
), simvastatin (Cat. #
HY-17502
) and cholesterol (Cat. #
HY-N0322A
) were purchased from
MCE
. FPP (Cat.
(5)
Oral Zoledronic acid bisphosphonate for the treatment of chronic low back pain with associated Modic changes: A pilot randomized controlled trial
Journal of orthopaedic research : official publication of the Orthopaedic Research Society
December 1, 2022
Shea GKH, Zhang C, Suen WS, Cheung PWH, Cheung JPY, Maatta J, Karppinen J, Samartzis D.
(6)
Various pathways of zoledronic acid against osteoclasts and bone cancer metastasis: a brief review
BMC cancer
November 3, 2020
Wang L, Fang D, Xu J, Luo R.
(7)
Zoledronic acid inhibits osteoclast differentiation and function through the regulation of NF-κB and JNK signalling pathways
International journal of molecular medicine
August 1, 2019
Huang XL, Huang LY, Cheng YT, Li F, Zhou Q, Wu C, Shi QH, Guan ZZ, Liao J, Hong W.
(8)
Zoledronate Enhances Osteocyte-Mediated Osteoclast Differentiation by IL-6/RANKL Axis
International journal of molecular sciences
March 22, 2019
Kim HJ, Kim HJ, Choi Y, Bae MK, Hwang DS, Shin SH, Lee JY.
(9)
Dose-dependent inhibitory effects of zoledronic acid on osteoblast viability and function in vitro
Molecular medicine reports
January 1, 2016
Huang X, Huang S, Guo F, Xu F, Cheng P, Ye Y, Dong Y, Xiang W, Chen A.
(10)
High-dose zoledronic acid impacts bone remodeling with effects on osteoblastic lineage and bone mechanical properties
Clinical cancer research : an official journal of the American Association for Cancer Research
September 15, 2009
Pozzi S, Vallet S, Mukherjee S, Cirstea D, Vaghela N, Santo L, Rosen E, Ikeda H, Okawa Y, Kiziltepe T,
et al
.
(11)
Binding of 4-methylumbelliferyl alpha-d-mannopyranoside to dimeric and tetrameric concanavalin A: equilibria and kinetic study using temperature-jump relaxation of fluorescence quenching [proceeding]
Archives internationales de physiologie et de biochimie
February 1, 1977
Loontiens FG, Clegg RM, Jovin TM.
<<
<
>
>>
Reviews
Be the First to Write a Review!
Zoledronic Acid from MedChemExpress
Supplier Page
View Company Product Page
$96.00
Product Specs
Company Info
Citations
Reviews
Back To Top